Regulation of entheseal IL-23 expression by IL-4 and IL-13 as an explanation for arthropathy development under dupilumab therapy.
Rheumatology (Oxford)
; 60(5): 2461-2466, 2021 05 14.
Article
in En
| MEDLINE
| ID: mdl-33253386
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interleukin-4
/
Interleukin-13
/
Eczema
/
Interleukin-23
/
Antibodies, Monoclonal, Humanized
/
Enthesopathy
Limits:
Humans
Language:
En
Journal:
Rheumatology (Oxford)
Journal subject:
REUMATOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
United kingdom
Country of publication:
United kingdom